Diagnostic Center | July 31, 2025
Roche presents new Alzheimer’s research at AAIC 2025
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease